LNSR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
LENSAR Inc (LNSR) is not a strong buy for a beginner, long-term investor at this time. The stock is experiencing bearish technical indicators, hedge fund selling, and lacks strong positive catalysts. While the company has shown financial improvement in revenue and net income, the risks surrounding its acquisition and operational challenges make it prudent to hold off on investing until clearer positive signals emerge.
The technical indicators for LNSR are bearish. The MACD is below 0 and negatively contracting, the RSI is neutral at 47.232, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level (11.819) with support at 11.28 and resistance at 12.357. Overall, the trend suggests weakness.
The company is working on a promising acquisition by Alcon, which could enhance its market position if regulatory approvals are secured. Additionally, its ALLY Robotic Cataract Laser System, which combines AI and dual-modality lasers, has potential for improving surgical efficiency and reducing costs.
The acquisition faces regulatory risks and potential delays, which could negatively impact the stock price. Hedge funds have significantly increased selling activity (up 303.64% last quarter), and insiders remain neutral with no significant trading trends. The gross margin has dropped by 9% YoY, indicating operational challenges.
In Q3 2025, LENSAR reported a 5.74% YoY revenue increase to $14.316M and a significant improvement in net income (-$3.713M, up 147.20% YoY). EPS also improved to -0.31 (up 138.46% YoY). However, gross margin dropped to 40.56%, down 9% YoY, signaling cost pressures.
No data available for analyst ratings or price target changes.
